Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 1 Dec 2014

Singh K, Stempora L, Harvey R D, Kirk A D, Larsen C P, Blazar B R, Kean L S

Abstract excerpt

Many critical issues remain concerning how best to deploy adoptive regulatory T cell (Treg) immunotherapy to the clinic. These include a determination of their pharmacokinetic characteristics, their optimal dose, their phenotypic stability and the best therapies with which to pair Tregs. By perfo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adoptive Transfer
Share to Fluoresceins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Half-Life

Share to Interleukin-2 Receptor alpha Subunit

Share to Sirolimus

Share to Succinimides

Share to Tacrolimus

Share to Transplantation, Autologous

Source

Open in PubMed Open full text

Identifiers

PMID: 25359003
DOI: 10.1111/ajt.12934
PMCID: PMC4236286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25359003-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.PMID 25359003Read ↗

IL2 enhances ex-vivo expanded regulatory T cell persistence after adoptive transferSemantic proximity Read ↗

Selective impact on regulatory T cells with sustained functional phenotypes by the interleukin-2 mutein VIS171 in a nonhuman primate model.Semantic proximity Read ↗

Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cellsSemantic proximity Read ↗

Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates.Semantic proximity Read ↗

Clinical development of gene edited tacrolimus-resistant Treg (FKBP12 <sup>KO</sup> -Treg) to enable simultaneous immunosuppression and support of immune regulationSemantic proximity Read ↗

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.Semantic proximity Read ↗

Regulatory T-cell therapy for transplantationSemantic proximity Read ↗

CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.Semantic proximity Read ↗

Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapySemantic proximity Read ↗

The time is crucial for ex vivo expansion of T regulatory cells for therapy.Semantic proximity Read ↗

Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques.Semantic proximity Read ↗

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.